期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

重组激活型Ⅶ因子治疗产后大出血的应用进展 被引量：3

原文传递
导出
摘要 产后出血是临床常见且严重的产后并发症，是导致我国产妇死亡的首位原因。产后出血发生突然，常导致患者出现严重并发症，甚至死亡。
作者 薛春红 曾万江
机构地区 华中科技大学同济医学院附属同济医院妇产科
出处 《中华围产医学杂志》 CAS 2011年第5期316-318,共3页 Chinese Journal of Perinatal Medicine
关键词 产后大出血 激活型 应用 治疗 因子 重组 产后出血 产妇死亡
分类号 R714.461 [医药卫生—妇产科学]
  • 相关文献

参考文献31

  • 1Kastner ES,Figueroa R,Garry D,et al.Emergency peripartum hysterectomy:experience at a community teaching hospital.Obstet Gynecol,2002,99:971-975.
  • 2Smith J,Mousa HA.Peripartum hysterectomy for primary postpartum haemorrhage:incidence and maternal morbidity.J Obstet Gynaecol,2007,27:44-47.
  • 3刘俊涛,韩凤珍,边旭明,郎景和.产后出血的干预性治疗[J].中华围产医学杂志,2002,5(2):99-101. 被引量：10
  • 4Roddie PH,Ludlam CA.Recombinant coagulation factors.Blood Rev,1997,11:169-177.
  • 5Mariani G,Lapecorella M,Dolce A.Steps towards an effective treatment strategy in congenital factor Ⅶ deficiency.Semin Hematol,2006,43:S42-S47.
  • 6White GC 2nd.Congenital and acquired platelet disorders:current dilemmas and treatment strategies.Semin Hematol,2006,43:S37-S41.
  • 7Kenet G,Walden R,Eldad A,et al.Treatment of traumatic bleeding with recombinant factor Ⅶ a.Lancet,1999,354:1879.
  • 8Franchini M,Zaffanello M,Veneri D.Recombinant factor Ⅶ a.An update on its clinical use.Thromb Haemost,2005,93:1027-1035.
  • 9MacLaren R,Weber LA,Brake H,et al.A multicenter assessment of recombinant factor Ⅶ a off-label usage:clinical experiences and associated outcomes.Transfusion,2005,45:1434-1442.
  • 10Ahonen J,Jokela R,Korttila K.An open non-randomized study of recombinant activated factor Ⅶ in major postpartum haemorrhage.Acta Anaesthesiol Scand,2007,51:929-936.

二级参考文献20

  • 1薛敏.血管介入技术在晚期产后出血诊治中的应用[J].中国实用妇科与产科杂志,1999,15(5):317-317.
  • 2王淑贞.实用妇产科[M].北京:人民卫生出版社,1993.443-450.
  • 3Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Ferraris SP, et al. Perioperative blood transfusion and blood conservation in cardiac surgery :the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg, 2007,83 Suppl 5 :S27-86.
  • 4Warren O, Mandal K, Hadjianastassiou V, et al. Recombinant activated factor Ⅶ in cardiac surgery.: a systematic review. Ann Thorac Surg,2007 ,83 :707-714.
  • 5Hyllner M,Houltz E,Jeppsson A. Recombinant activated factor ⅦG in the management of life-threatening bleeding in cardiac surgery. Eur J Cardiothorac Surg,2005 ,28 :254-258.
  • 6Tritapepe L,De Santis V, Vitale D, et al. Recombinant activated factor Ⅶ for refractory bleeding after acute aortic dissection surgery:a propensity score analysis. Crit Care Med ,2007,35:1685- 1690.
  • 7Leibovitch L, Kenet G, Mazor K, et al. Recombinant activated factor Ⅶ for life-threatening pulmonary hemorrhage after pediatric cardiac surgery. Pediatr Crit Care Med ,2003,4:444-446.
  • 8Karkouti K, Beattie WS, Crowther MA, et al. The role of recombinant factor Ⅶa in on-pump cardiac surgery :proceedings of the Canadian Consensus Conference. Can J Anaesth, 2007,54: 573-582.
  • 9McCall P,Story DA,Karapillai D. Audit of factor Ⅶa for bleeding resistant to conventional therapy following complex cardiac surgery, Can J Anaesth,2006,53:926-933.
  • 10Romagnoli S, Bevilacqua S, Gelsomino S, et al. Small-dose recombinant activated factor Ⅶ (NovoSeven) in cardiac surgery. Anesth Analg,2006,102 : 1320-1326.

共引文献12

同被引文献23

引证文献3

二级引证文献14

中华围产医学杂志
2011年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部